CALGARY, ALBERTA--(Marketwire - October 17, 2007) - This press release is issued jointly by Dr. Francesco Bellini and Rocabe Investments Inc. (“Rocabe”), as required by Canadian provincial securities legislation. Until this day, 18056 Yukon Inc. (“Yukon”) owned 100% of the outstanding class F special shares and 1324286 Alberta Ltd (“Alberta”), a wholly-owned subsidiary of FMRC Family Trust (“FMRC”), owned 50% of the outstanding common shares of Picchio Pharma Inc. (“Picchio Pharma”). Pursuant to applicable securities legislation, Dr. Francesco Bellini is deemed to be a joint actor of Yukon and the trustees of FMRC, Messrs John W. Churchill and Vernon H. Strang (the “Trustees”), are deemed to be joint actors of FMRC, Alberta and Picchio Pharma. For reporting purposes under the Early Warning System, Dr. Bellini is therefore obliged to include the holdings of Yukon in determining his ownership of the securities of Neurochem Inc. (“Neurochem”) and FMRC, the Trustees and Alberta are obliged to include the holdings of Picchio Pharma and P. P. Luxco Holdings II s.a.r.l. (“Luxco”), a wholly-owned subsidiary of Picchio Pharma. Dr. Francesco Bellini is an insider of Neurochem by virtue of his being one of its directors and its Chairman of the Board and CEO.
